BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11549776)

  • 1. Coagulopathy of acute promyelocytic leukemia.
    Falanga A; Barbui T
    Acta Haematol; 2001; 106(1-2):43-51. PubMed ID: 11549776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated intravascular coagulation in acute leukemia.
    Barbui T; Falanga A
    Semin Thromb Hemost; 2001 Dec; 27(6):593-604. PubMed ID: 11740683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.
    Falanga A; Rickles FR
    Best Pract Res Clin Haematol; 2003 Sep; 16(3):463-82. PubMed ID: 12935963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.
    Barbui T; Finazzi G; Falanga A
    Blood; 1998 May; 91(9):3093-102. PubMed ID: 9558362
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in the management of coagulopathy in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
    Tallman MS; Hakimian D; Kwaan HC; Rickles FR
    Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
    Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute promyelocytic leukaemia in the all trans retinoic acid era.
    DeLoughery TG; Goodnight SH
    Med Oncol; 1996 Dec; 13(4):233-40. PubMed ID: 9152974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia.
    Kawai Y; Watanabe K; Kizaki M; Murata M; Kamata T; Uchida H; Moriki T; Yokoyama K; Tokuhira M; Nakajima H
    Am J Hematol; 1994 Jul; 46(3):184-8. PubMed ID: 8192147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy.
    Pogliani EM; Rossini F; Casaroli I; Maffe P; Corneo G
    Acta Haematol; 1997; 97(4):228-30. PubMed ID: 9158667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open issues on bleeding and thrombosis in acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Thromb Res; 2010 Apr; 125 Suppl 2():S51-4. PubMed ID: 20434005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.
    Kwaan HC; Cull EH
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):11-8. PubMed ID: 24907013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom.
    Tallman MS; Brenner B; Serna Jde L; Dombret H; Falanga A; Kwaan HC; Liebman H; Raffoux E; Rickles FR
    Leuk Res; 2005 Mar; 29(3):347-51. PubMed ID: 15661272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
    Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
    Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential consumption of heparin cofactor II in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Kario K; Matsuo T; Kodama K; Katayama S; Kobayashi H
    Thromb Res; 1992 May; 66(4):435-44. PubMed ID: 1412208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unique hemostatic dysfunction in acute promyelocytic leukemia.
    Kwaan HC
    Semin Thromb Hemost; 2014 Apr; 40(3):332-6. PubMed ID: 24590422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?
    Mantha S; Tallman MS; Soff GA
    Curr Opin Hematol; 2016 Mar; 23(2):121-6. PubMed ID: 26760586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in hemostasis in acute promyelocytic leukemia.
    Kwaan HC; Wang J; Boggio LN
    Hematol Oncol; 2002 Mar; 20(1):33-41. PubMed ID: 11921015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.